Home › Bayer spending $100 million on Berkeley hemophilia drug facility
 

Keywords :   


Bayer spending $100 million on Berkeley hemophilia drug facility

2015-04-30 00:03:51| Chemicals - Topix.net

Bayer HealthCare is spending $100 million over the next two years building a product testing facility here for a new hemophilia drug, a project that will create 325,000 hours of construction work, officials said during a news conference Wednesday. Bayer's Berkeley campus, which spans three city blocks on 7th Street between Dwight Way and Grayson Street, manufactures a drug for people with hemophilia A called Kogenate.

Tags: million drug facility spending

Category:Chemicals

Latest from this category

All news
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
27.09Positive Development for Jotun After First Eight Months of 2028
27.09Graco Signs Definitive Agreement to Acquire Corob
27.09BASF Presents New Corporate Strategy
26.09Advanced Polymer Coatings Signs Deal to Coat for New Build Tankers Union Maritime
26.09Jeff McManus Appointed Senior VP of Americas at allnex
26.09AkzoNobel Develops Particle Technology for Metal Effect Powder Coatings
26.09Behr Paint Company Introduces Women in Paint in Canada
Chemicals »
29.09When to recline and how to share armrests: Rules for avoiding a mid-flight row
29.09Atlantic Tropical Weather Outlook
29.09Eastern North Pacific Tropical Weather Outlook
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 12
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 12
28.09Hurricane Isaac Forecast Advisory Number 12
More »